Cargando…

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study

OBJECTIVE: To assess whether adding or switching to sulfonylureas is associated with an increased risk of myocardial infarction, ischaemic stroke, cardiovascular death, all cause mortality, and severe hypoglycaemia, compared with remaining on metformin monotherapy in patients with type 2 diabetes. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douros, Antonios, Dell’Aniello, Sophie, Yu, Oriana Hoi Yun, Filion, Kristian B, Azoulay, Laurent, Suissa, Samy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050517/ https://www.ncbi.nlm.nih.gov/pubmed/30021781 http://dx.doi.org/10.1136/bmj.k2693

Ejemplares similares

Cardiac glycosides use and the risk of lung cancer: a nested case–control study
por: Couraud, Sébastien, et al.
Publicado: (2014)

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
por: Suissa, Samy, et al.
Publicado: (2012)

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
por: Suissa, Samy, et al.
Publicado: (2022)

Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
por: Ernst, Pierre, et al.
Publicado: (2011)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
por: Filion, Kristian B, et al.
Publicado: (2020)

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study
por: Martinez, Carlos, et al.
Publicado: (2010)

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
por: Huiart, L, et al.
Publicado: (2011)

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
por: Loo, Simone Y, et al.
Publicado: (2018)

Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study
por: Renoux, Christel, et al.
Publicado: (2015)

Validity of an algorithm to identify cardiovascular deaths from administrative health records: a multi-database population-based cohort study
por: Lix, Lisa M., et al.
Publicado: (2021)

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
por: Abrahami, Devin, et al.
Publicado: (2018)

Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
por: Volke, Vallo, et al.
Publicado: (2022)

Metformin and the Risk of Cancer: Time-related biases in observational studies
por: Suissa, Samy, et al.
Publicado: (2012)

Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Suissa, Samy, et al.
Publicado: (2013)

Response to Bodmer et al. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Response to Yang and Chan. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Subclinical hypothyroidism and the risk of cancer incidence and cancer mortality: a systematic review
por: Gómez-Izquierdo, Juan, et al.
Publicado: (2020)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2022)

New Hypoglycaemic Therapies
por: Gale, Edwin A M
Publicado: (2000)

Research: Complications Self-reported non-severe hypoglycaemic events in Europe
por: Östenson, C G, et al.
Publicado: (2014)

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality
por: Shimoda, Masashi, et al.
Publicado: (2016)

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
por: Wang, Huan, et al.
Publicado: (2023)

A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
por: de Groot, Saskia, et al.
Publicado: (2018)

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
por: Lapi, Francesco, et al.
Publicado: (2013)

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study
por: Abrahami, Devin, et al.
Publicado: (2018)

Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom
por: Brunetti, Vanessa C., et al.
Publicado: (2022)

HYPOGLYCAEMIC PROPERTY OF SHILAJEET AND YASHADA BHASMA
por: Bharati,, et al.
Publicado: (1996)

YASADA BHASMA : AN EFFECTIVE HYPOGLYCAEMIC DRUG
por: Prasad, C.M., et al.
Publicado: (1989)

The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
por: Smiechowski, Brielan B., et al.
Publicado: (2013)

Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014)

Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria
por: Weitgasser, Raimund, et al.
Publicado: (2014)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study
por: Deng, Lan, et al.
Publicado: (2021)

Correction to: Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2019)

Oral Hypoglycaemic Agents: The First Thirty Years
por: Nabarro, John D. N.
Publicado: (1992)

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ffcnl8h0ec6lgg4g4vutkjhn66